Technologies are now available to explore epigenetic mechanisms in rodent models for carcinogenesis at a genome-wide level, for example by RRBS and ChIP-NGS, and to relate them to binding of ER or other TF to their respective response elements, gene expression, and tumor growth. The gene discussed is ESR1; the disease is neoplasm.